Robert Stewart
Psychiatry · Louisville, KYNPI 1750423034
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $562,962 of the $651,061 with a category attached, or 86.5%. AbbVie accounts for 75.2% of it on its own, with 33 other manufacturers making up the rest. Among psychiatry clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,349 payments — averaging $482.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$490K
- Axsome Therapeutics, Inc.$54K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$31K
- Vanda Pharmaceuticals Inc.$28K
- Otsuka America Pharmaceutical, Inc.$27K
- Takeda Pharmaceuticals U.S.A., Inc.$12K
- plus $9K from 28 others
What the payments were for
- Consulting fees$36,7506%
- Speaking & faculty fees$562,96286%
- Travel & lodging$32,5065%
- Food & beverage$18,6643%
- Education$1790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$651,061 in reported general payments places this provider in the 95th percentile of 348 psychiatry providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $109,740 |
| CaplytaLumateperone Tosylate | 19 | $42,853 |
| TrintellixVortioxetine Hydrobromide | 44 | $29,832 |
| AuvelityDextromethorphan Hbr/Bupropion | 20 | $26,134 |
| QuviviqDaridorexant Hcl | 24 | $12,540 |
| Lurasidone Hcl | 36 | $7,858 |
| VyvanseLisdexamfetamine Dimesylate | 17 | $7,346 |
| Lisdexamfetamine Dimesylate | 16 | $6,890 |
| Asenapine Maleate | 19 | $4,155 |
| Modafinil | 28 | $3,521 |
| Bupropion Hcl SrBupropion Hcl | 128 | $3,095 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 85 | $3,065 |
| Divalproex Sodium ErDivalproex Sodium | 46 | $2,777 |
| Zolpidem Tartrate ErZolpidem Tartrate | 31 | $2,767 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 36 | $2,691 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $134 | $109,74013 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $31,402 | $42,85319 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $11,944 | $37,17861 claims |
| Axsome Therapeutics, Inc.Auvelity | $54,482 | $26,13420 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $3,587 | $12,54024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 348 psychiatry providers in Kentucky.
Other psychiatry in Louisville
- Rifaat El-MallakhLouisville$1.6M
- Ali FarooquiLouisville$393K
- Stephanie HallLouisville$106K
- Kelly ClarkLouisville$14K
- Michael HarrisLouisville$13K
- Yelena VaninaLouisville$12K
- Mohamed KhodeirLouisville$9K
- Kevin BaysLouisville$9K
- Terry HaganLouisville$8K
- Ronald McGavicLouisville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.